Taken private by CPS Capital in Aug 2024
DOC - CloudMD Software & Services Inc.
TSXV
->
Healthcare
->
Health Information Services
Vancouver,
Canada
Type: Equity
DOC price evolution
DOC
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5.16 | $8.93 | ||
| Short term investments | ||||
| Net receivables | $64.98 | $59.66 | $18.17 | $117.73 |
| Inventory | $0.02 | $0.02 | ||
| Total current assets | $245.41 | $166.54 | $31.67 | $274.51 |
| Long term investments | ||||
| Property, plant & equipment | $16320.12 | $16838.43 | $4.3 | $4657.83 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $19969.77 | $20179.71 | $80.1 | $5155.62 |
| Current liabilities | ||||
| Accounts payable | $749.88 | $977.21 | $17.61 | $8.36 |
| Deferred revenue | ||||
| Short long term debt | $19.92 | $18.18 | ||
| Total current liabilities | $1058.16 | $1515.71 | $40.97 | $270.48 |
| Long term debt | $8583.38 | $8574.46 | $4.59 | $1973.04 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $11406.93 | $11422.21 | $51.53 | $2392.09 |
| Shareholders' equity | ||||
| Retained earnings | -$4968.82 | -$4844.68 | -$296.53 | -$1061.29 |
| Other shareholder equity | -$12.38 | $42.3 | $16.78 | $0.72 |
| Total shareholder equity | $28.57 | $33.42 | ||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $8.93 | $24.06 | $45.08 | $59.72 |
| Short term investments | ||||
| Net receivables | $117.73 | $112.81 | $24.72 | $2.01 |
| Inventory | $0.02 | $0.98 | $3.42 | $0.73 |
| Total current assets | $274.51 | $120.54 | $75.67 | $63.37 |
| Long term investments | $0.34 | $0.02 | ||
| Property, plant & equipment | $4657.83 | $4748.15 | $11.32 | $5.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $5155.62 | $5096.88 | $327.36 | $121.86 |
| Current liabilities | ||||
| Accounts payable | $8.36 | $4.39 | $6.65 | $7.01 |
| Deferred revenue | ||||
| Short long term debt | $18.18 | $4.17 | $4.41 | $1.79 |
| Total current liabilities | $270.48 | $257.27 | $50.57 | $7.62 |
| Long term debt | $1973.04 | $1818.12 | $29.04 | $5.52 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $2392.09 | $2223.9 | $106.57 | $15.18 |
| Shareholders' equity | ||||
| Retained earnings | -$1061.29 | -$881.67 | -$40.7 | -$12.9 |
| Other shareholder equity | $0.72 | $5.18 | $2.42 | $67.85 |
| Total shareholder equity | $33.42 | $115.67 | $220.79 | $106.69 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $700.4 | $135.47 | ||
| Cost of revenue | ||||
| Gross Profit | $420.12 | $90.91 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $303.24 | $55.16 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1.94 | |||
| Interest expense | -$74.11 | -$21.69 | ||
| Net income | ||||
| Net income | $85.67 | $6.79 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $543.46 | $102.33 | $15.02 | |
| Cost of revenue | $68.28 | $9.26 | ||
| Gross Profit | $360.8 | $34.05 | $5.76 | |
| Operating activities | ||||
| Research & development | $2.96 | $1.84 | ||
| Selling, general & administrative | $37.68 | $12.95 | ||
| Total operating expenses | $229.85 | $132.5 | $28.85 | |
| Operating income | -$30.17 | -$13.83 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.57 | -$1.5 | ||
| Interest expense | -$80.27 | $1.09 | $0.26 | |
| Net income | ||||
| Net income | $41.88 | -$30.73 | -$12.33 | |
| Income (for common shares) | -$30.73 | -$12.33 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | -$4.85 | |||
| Operating activities | ||||
| Depreciation | $0.53 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$1.68 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $119.97 | $89.75 | -$0.41 | -$114.02 |
| Financing activities | ||||
| Dividends paid | -$584.96 | -$375.14 | -$220.43 | |
| Sale and purchase of stock | ||||
| Net borrowings | -$1.63 | |||
| Total cash flows from financing | -$833.92 | -$568.24 | -$1.63 | -$10.36 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $73.02 | -$9.73 | -$3.76 | $149.05 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$30.74 | -$12.33 | ||
| Operating activities | ||||
| Depreciation | $2.69 | $0.86 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$21.86 | -$7.51 | ||
| Investing activities | ||||
| Capital expenditures | -$2.67 | -$0.16 | ||
| Investments | ||||
| Total cash flows from investing | -$114.02 | -$38.47 | -$69.91 | -$10.55 |
| Financing activities | ||||
| Dividends paid | -$220.43 | -$209.42 | ||
| Sale and purchase of stock | $62.68 | $84.71 | ||
| Net borrowings | $18.61 | -$2.51 | ||
| Total cash flows from financing | -$10.36 | -$222.07 | $77.07 | $76.07 |
| Effect of exchange rate | $0.07 | |||
| Change in cash and equivalents | $149.05 | -$2.15 | -$14.63 | $58.02 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 699.41M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 405.53% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 71.58 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.23 |
| Quick ratio | N/A |